Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | July 03, 2023 01:37pm

Gainers

  • SQZ Biotechnologies (NYSE:SQZ) shares increased by 68.1% to $0.45 during Monday's regular session. The current volume of 30.0 million shares is 44863.5% of SQZ Biotechnologies's average full-day volume over the last 100 days (last updated at 13:37 EST). The market value of their outstanding shares is at $13.3 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) shares rose 31.68% to $0.25. Nymox Pharmaceutical's stock is trading at a volume of 3.3 million shares as of 13:37 EST. This is 5697.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares increased by 31.11% to $2.36. Trading volume for Ensysce Biosciences's stock is 11.1 million as of 13:37 EST. This is 1720.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.8 million.
  • IMAC Hldgs (NASDAQ:BACK) shares increased by 27.63% to $0.14. Trading volume for IMAC Hldgs's stock is 40.4 million as of 13:37 EST. This is 1456.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.6 million.
  • Journey Medical (NASDAQ:DERM) stock increased by 23.27% to $1.96. As of 13:37 EST, Journey Medical's stock is trading at a volume of 488.0K, which is 502.3% of its average full-day volume over the last 100 days. The company's market cap stands at $35.5 million.
  • Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 23.07% to $40.37. Ventyx Biosciences's stock is trading at a volume of 3.0 million shares as of 13:37 EST. This is 378.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.3 billion.

Losers

  • Protagonist Therapeutics (NASDAQ:PTGX) stock declined by 19.7% to $22.18 during Monday's regular session. The current volume of 7.5 million shares is 674.2% of Protagonist Therapeutics's average full-day volume over the last 100 days (last updated at 13:37 EST). The market value of their outstanding shares is at $1.2 billion.
  • Xtant Medical Hldgs (AMEX:XTNT) shares fell 16.32% to $0.78. Trading volume for this security as of 13:37 EST is 82.6K, which is 444.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $84.7 million.
  • Baudax Bio (NASDAQ:BXRX) shares decreased by 14.63% to $1.0. As of 13:37 EST, Baudax Bio's stock is trading at a volume of 7.1 million, which is 262.6% of its average full-day volume over the last 100 days. The company's market cap stands at $6.0 million.
  • Icosavax (NASDAQ:ICVX) shares declined by 14.51% to $8.49. Trading volume for this security as of 13:37 EST is 371.6K, which is 172.1% of its average full-day volume over the last 100 days. The company's market cap stands at $351.7 million.
  • Omega Therapeutics (NASDAQ:OMGA) shares decreased by 14.47% to $4.79. Omega Therapeutics's stock is trading at a volume of 234.2K shares as of 13:37 EST. This is 147.3% of its average full-day volume over the last 100 days. The company's market cap stands at $263.5 million.
  • Laboratory Corp (NYSE:LH) stock declined by 13.38% to $209.05. Trading volume for this security as of 13:37 EST is 882.5K, which is 147.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.5 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BACK BXRX DERM ENSC ICVX LH NYMX OMGA PTGX SQZ VTYX XTNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist